| pubmed-article:18030468 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18030468 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
| pubmed-article:18030468 | lifeskim:mentions | umls-concept:C0011306 | lld:lifeskim |
| pubmed-article:18030468 | lifeskim:mentions | umls-concept:C0003320 | lld:lifeskim |
| pubmed-article:18030468 | lifeskim:mentions | umls-concept:C0007585 | lld:lifeskim |
| pubmed-article:18030468 | lifeskim:mentions | umls-concept:C0449416 | lld:lifeskim |
| pubmed-article:18030468 | lifeskim:mentions | umls-concept:C1881488 | lld:lifeskim |
| pubmed-article:18030468 | lifeskim:mentions | umls-concept:C0770246 | lld:lifeskim |
| pubmed-article:18030468 | lifeskim:mentions | umls-concept:C1515895 | lld:lifeskim |
| pubmed-article:18030468 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:18030468 | pubmed:dateCreated | 2008-3-27 | lld:pubmed |
| pubmed-article:18030468 | pubmed:abstractText | Recent preclinical and clinical evidence suggests the use of allogeneic tumor as a source of antigen for DC-based immunotherapy against cancer. We hypothesized that addition of allogeneic tumor lysate to monocyte-derived DC culture could serve a dual purpose: (1) antigen source and (2) protein supplementation of DC culture media. Protein supplementation whether of known origin (human serum/plasma, fetal bovine serum, human serum albumin) or undeclared origin ("serum-free" media) is a source of variability and bias. We addressed the question whether protein supplementation can be omitted in the presence of allogeneic tumor lysate. | lld:pubmed |
| pubmed-article:18030468 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18030468 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18030468 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18030468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18030468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18030468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18030468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18030468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18030468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18030468 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18030468 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:18030468 | pubmed:issn | 0340-7004 | lld:pubmed |
| pubmed-article:18030468 | pubmed:author | pubmed-author:SachetMonikaM | lld:pubmed |
| pubmed-article:18030468 | pubmed:author | pubmed-author:FriedlJosefJ | lld:pubmed |
| pubmed-article:18030468 | pubmed:author | pubmed-author:PfragnerRoswi... | lld:pubmed |
| pubmed-article:18030468 | pubmed:author | pubmed-author:GnantMichaelM | lld:pubmed |
| pubmed-article:18030468 | pubmed:author | pubmed-author:StiftAntonA | lld:pubmed |
| pubmed-article:18030468 | pubmed:author | pubmed-author:Bachleitner-H... | lld:pubmed |
| pubmed-article:18030468 | pubmed:author | pubmed-author:DubskyPeterP | lld:pubmed |
| pubmed-article:18030468 | pubmed:author | pubmed-author:HaydenHubertH | lld:pubmed |
| pubmed-article:18030468 | pubmed:author | pubmed-author:HasslerMichae... | lld:pubmed |
| pubmed-article:18030468 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18030468 | pubmed:volume | 57 | lld:pubmed |
| pubmed-article:18030468 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18030468 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18030468 | pubmed:pagination | 859-70 | lld:pubmed |
| pubmed-article:18030468 | pubmed:meshHeading | pubmed-meshheading:18030468... | lld:pubmed |
| pubmed-article:18030468 | pubmed:meshHeading | pubmed-meshheading:18030468... | lld:pubmed |
| pubmed-article:18030468 | pubmed:meshHeading | pubmed-meshheading:18030468... | lld:pubmed |
| pubmed-article:18030468 | pubmed:meshHeading | pubmed-meshheading:18030468... | lld:pubmed |
| pubmed-article:18030468 | pubmed:meshHeading | pubmed-meshheading:18030468... | lld:pubmed |
| pubmed-article:18030468 | pubmed:meshHeading | pubmed-meshheading:18030468... | lld:pubmed |
| pubmed-article:18030468 | pubmed:meshHeading | pubmed-meshheading:18030468... | lld:pubmed |
| pubmed-article:18030468 | pubmed:meshHeading | pubmed-meshheading:18030468... | lld:pubmed |
| pubmed-article:18030468 | pubmed:meshHeading | pubmed-meshheading:18030468... | lld:pubmed |
| pubmed-article:18030468 | pubmed:meshHeading | pubmed-meshheading:18030468... | lld:pubmed |
| pubmed-article:18030468 | pubmed:meshHeading | pubmed-meshheading:18030468... | lld:pubmed |
| pubmed-article:18030468 | pubmed:meshHeading | pubmed-meshheading:18030468... | lld:pubmed |
| pubmed-article:18030468 | pubmed:meshHeading | pubmed-meshheading:18030468... | lld:pubmed |
| pubmed-article:18030468 | pubmed:meshHeading | pubmed-meshheading:18030468... | lld:pubmed |
| pubmed-article:18030468 | pubmed:meshHeading | pubmed-meshheading:18030468... | lld:pubmed |
| pubmed-article:18030468 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18030468 | pubmed:articleTitle | Allogeneic tumor lysate can serve as both antigen source and protein supplementation for dendritic cell culture. | lld:pubmed |
| pubmed-article:18030468 | pubmed:affiliation | Department of Surgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria. peter.dubsky@meduniwien.ac.at | lld:pubmed |
| pubmed-article:18030468 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18030468 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18030468 | lld:pubmed |
